ALFA News
Straight from the exchange filing
Every announcement Wanbury has filed with the exchanges that we have reported, newest first. Each story links the original filing.
Every Wanbury announcement on ALFA FilingsSee filings →Reference market data from a third-party provider, as of the most recent story. Not a valuation or a recommendation.
Wanbury Limited enters paediatric dermatology with the launch of berrysoft baby products across India. Latest quarterly revenue reached ₹165.58 crore in June 2026.
Wanbury Limited receives EDQM approval for Rivaroxaban API and USFDA DMF clearances for Paroxetine HCI and Metformin HCI, targeting the EU and US pharma markets.
Wanbury Ltd expands global API reach with DMF submissions for Diphenhydramine HCl and Paroxetine HCl. Patalganga facility clears Korea MFDS audit with zero observations.
